Embecta Corp

In a Stage 4 decline, EMBC shows exhaustion after the May capitulation, qualifying for a mean-reversion setup at intermediate-cycle lows. However, price remains extended below declining EMAs and the short-term trend is down, so immediate entry is unattractive. We will stalk for a clean consolidation resolution or a pullback into resistance zones before buying.

• ↑9.02% dividend yield plus $41M Q3 free cash flow.
• ↑Q3 revenue up $50M sequentially, signaling operational recovery.
• ↓Q3 revenue $272M, down 8.1% YoY; U.S. sales dropped 24.6%.